Simplex Trading
ABCL icon

Simplex Trading’s AbCellera Biologics ABCL Stock Holding History

Simplex Trading’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$702K Buy
+201,236
New +$724K ﹤0.01% 2880
2025
Q4 		– Sell
-68,077
Closed -$304K – 8347
2025
Q3 		$342K Buy
+68,077
New +$300K ﹤0.01% 4299
2025
Q1 		– Sell
-6,176
Closed -$17.7K – 8368
2024
Q4 		$18K Sell
6,176
-58,007
-90% -$162K ﹤0.01% 6746
2024
Q3 		$166K Buy
64,183
+26,998
+73% +$74.8K ﹤0.01% 4703
2024
Q2 		$110K Sell
37,185
-16,289
-30% -$61.6K ﹤0.01% 5279
2024
Q1 		$242K Sell
53,474
-3,386
-6% -$17.3K ﹤0.01% 4640
2023
Q4 		$324K Buy
56,860
+52,851
+1,318% +$245K ﹤0.01% 4135
2023
Q3 		$18K Sell
4,009
-1,453
-27% -$8.84K ﹤0.01% 6689
2023
Q2 		$35K Sell
5,462
-5,885
-52% -$40.2K ﹤0.01% 6169
2023
Q1 		$85K Sell
11,347
-89,144
-89% -$809K ﹤0.01% 5325
2022
Q4 		$1.02M Buy
100,491
+39,705
+65% +$459K ﹤0.01% 2445
2022
Q3 		$601K Buy
60,786
+36,004
+145% +$395K ﹤0.01% 3254
2022
Q2 		$263K Sell
24,782
-26,174
-51% -$222K ﹤0.01% 4267
2022
Q1 		$496K Sell
50,956
-34,468
-40% -$326K ﹤0.01% 3853
2021
Q4 		$1.22M Buy
85,424
+57,142
+202% +$867K ﹤0.01% 2602
2021
Q3 		$581K Buy
28,282
+960
+4% +$17K ﹤0.01% 3863
2021
Q2 		$601K Buy
27,322
+24,152
+762% +$666K ﹤0.01% 3878
2021
Q1 		$107K Buy
+3,170
New +$126K ﹤0.01% 5644

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's ABCL Position: Q1 2026 in Review

Simplex Trading opened a new position in AbCellera Biologics (ABCL) in Q1 2026: 201,236 shares worth $702K. The stake represents ﹤0.01% of the portfolio and ranks #2880 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ABCL as recently as Q3 2025.

Simplex Trading first reported a position in ABCL in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.22M in Q4 2021. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Simplex Trading held 201,236 shares of AbCellera Biologics worth $702K as of Q1 2026.
  • AbCellera Biologics was a new Simplex Trading position in Q1 2026.
  • AbCellera Biologics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #2880 holding.
  • Simplex Trading first reported a position in AbCellera Biologics in Q1 2021 and has held it in 18 quarters since.
  • Simplex Trading's AbCellera Biologics position peaked at $1.22M in Q4 2021.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.